Body mass change and anthropometric-related adverse events at week 24 in treatment-experienced HIV-infected patients receiving TMC114/r or control PIs in POWER 1, 2 and 3

Document Type

Journal Article

Publication Date

2006

Journal

Antiviral Therapy

Volume

11

Issue

7

Inclusive Pages

L21-L22

This document is currently not available here.

Share

COinS